Morgan Stanley’s ProShares Ultra Health Care RXL Stock Holding History

Morgan Stanley’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$89	Sell	1 -1	-50%	-$47	﹤0.01%	7971
2026 Q1	$101	Buy	2 +1	+100%	+$51	﹤0.01%	7796
2025 Q4	$86	Buy	+1	New	+$49	﹤0.01%	7722
2025 Q3	–	Sell	-123	Closed	-$5K	–	8339
2025 Q2	$5K	Buy	123 +54	+78%	+$2.22K	﹤0.01%	7030
2025 Q1	$3.4K	Buy	69 +67	+3,350%	+$3.27K	﹤0.01%	7079
2024 Q4	$92	Buy	+2	New	+$100	﹤0.01%	7478
2020 Q1	–	Sell	-20	Closed	-$1K	–	6689
2019 Q4	$1K	Buy	+20	New	+$559	﹤0.01%	6583
2019 Q1	–	Sell	-1,600	Closed	-$36K	–	6687
2018 Q4	$36K	Hold	1,600	–	–	﹤0.01%	5848
2018 Q3	$46K	Hold	1,600	–	–	﹤0.01%	5897
2018 Q2	$36K	Hold	1,600	–	–	﹤0.01%	5997
2018 Q1	$34K	Hold	1,600	–	–	﹤0.01%	5989
2017 Q4	$35K	Sell	1,600 -1,520	-49%	-$33K	﹤0.01%	5934
2017 Q3	$66K	Sell	3,120 -400	-11%	-$8.2K	﹤0.01%	5695
2017 Q2	$70K	Hold	3,520	–	–	﹤0.01%	5762
2017 Q1	$62K	Hold	3,520	–	–	﹤0.01%	5768
2016 Q4	$53K	Sell	3,520 -1,240	-26%	-$18.8K	﹤0.01%	5736
2016 Q3	$79K	Buy	4,760 +1,240	+35%	+$20.9K	﹤0.01%	5405
2016 Q2	$57K	Hold	3,520	–	–	﹤0.01%	5484
2016 Q1	$50K	Hold	3,520	–	–	﹤0.01%	5610
2015 Q4	$58K	Sell	3,520 -2,000	-36%	-$32K	﹤0.01%	5652
2015 Q3	$79K	Sell	5,520 -1,600	-22%	-$28.5K	﹤0.01%	5530
2015 Q2	$133K	Buy	7,120 +3,920	+123%	+$71.5K	﹤0.01%	5443
2015 Q1	$57K	Hold	3,200	–	–	﹤0.01%	5747
2014 Q4	$50K	Hold	3,200	–	–	﹤0.01%	5822
2014 Q3	$43K	Hold	3,200	–	–	﹤0.01%	5779
2014 Q2	$39K	Hold	3,200	–	–	﹤0.01%	5843
2014 Q1	$36K	Hold	3,200	–	–	﹤0.01%	5822
2013 Q4	$32K	Buy	+3,200	New	+$30.2K	﹤0.01%	5758

Other funds holding RXL

CAS

Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Morgan Stanley's RXL Position: Q2 2026 in Review

Morgan Stanley reduced its ProShares Ultra Health Care (RXL) stake by 50% in Q2 2026, selling an estimated $47 and leaving 1 share worth $89. The position accounts for ﹤0.01% of the portfolio, ranked #7971.

Morgan Stanley first reported a position in RXL in Q4 2013 and has held it in 28 quarters since. The position peaked at $133K in Q2 2015. 16 funds tracked by Wall St. Rank hold RXL as of Q2 2026.

Morgan Stanley held 1 share of ProShares Ultra Health Care worth $89 as of Q2 2026.
Morgan Stanley sold 1 ProShares Ultra Health Care share in Q2 2026, an estimated $47.
ProShares Ultra Health Care made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7971 holding.
Morgan Stanley first reported a position in ProShares Ultra Health Care in Q4 2013 and has held it in 28 quarters since.
Morgan Stanley's ProShares Ultra Health Care position peaked at $133K in Q2 2015.
16 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.